All Stories

  1. Fibrosis-4 index at diagnosis can predict all-cause mortality in patients with rheumatoid arthritis: A retrospective monocentric study

    Article • Modern Rheumatology, December 2018, Taylor & Francis

    Jun Yong park , Sang-Won Lee

  2. Fibrosis-matched outcomes between chronic hepatitis B patients with drug-induced virological response and inactive carriers

    Article • Liver International, October 2018, Wiley

    Jun Yong park

  3. Step-down strategy in antiviral resistant chronic hepatitis B patients who achieved viral suppression with rescue combination therapy

    Article • Future Virology, September 2018, Future Medicine

    Jun Yong park

  4. Sarcopenia is associated with the risk of significant liver fibrosis in metabolically unhealthy subjects with chronic hepatitis B

    Article • Alimentary Pharmacology & Therapeutics, June 2018, Wiley

    Jun Yong park

  5. Evolution and persistence of resistance-associated substitutions of hepatitis C virus after direct-acting antiviral treatment failures

    Article • Journal of Viral Hepatitis, June 2018, Wiley

    Jun Yong park

  6. Predictors of failure to detect early hepatocellular carcinoma in patients with chronic hepatitis B who received regular surveillance

    Article • Alimentary Pharmacology & Therapeutics, February 2018, Wiley

    Jun Yong park

  7. Serum cystatin C level: An excellent predictor of mortality in patients with cirrhotic ascites

    Article • Journal of Gastroenterology and Hepatology, January 2018, Wiley

    Jun Yong park

  8. Switching from tenofovir and nucleoside analogue therapy to tenofovir monotherapy in virologically suppressed chronic hepatitis B patients with antiviral resistance

    Article • Journal of Medical Virology, November 2017, Wiley

    Jun Yong park

  9. Feasibility of dynamic risk prediction for hepatocellular carcinoma development in patients with chronic hepatitis B

    Article • Liver International, September 2017, Wiley

    Jun Yong park

  10. Validation of PAGE-B model in Asian chronic hepatitis B patients receiving entecavir or tenofovir

    Article • Liver International, May 2017, Wiley

    Jun Yong park

  11. Using transient elastography to predict hepatocellular carcinoma recurrence after radiofrequency ablation

    Article • Journal of Gastroenterology and Hepatology, April 2017, Wiley

    Jun Yong park

  12. Conventional versus drug-eluting beads chemoembolization for hepatocellular carcinoma: Emphasis on the impact of tumor size

    Article • Journal of Gastroenterology and Hepatology, February 2017, Wiley

    Jun Yong park

  13. Wisteria floribunda agglutinin-positive human Mac-2 binding protein predicts the risk of HBV-related liver cancer development

    Article • Liver International, December 2016, Wiley

    MD Hyon-Suk Kim, Jun Yong park

  14. Tenofovir versus tenofovir plus entecavir for chronic hepatitis B with lamivudine resistance and entecavir resistance

    Article • Journal of Viral Hepatitis, October 2016, Wiley

    Jun Yong park

  15. Durability of the virological response after lamivudine discontinuation in lamivudine-resistant patients with a complete virological response after lamivudine and adefovir combination therapy

    Article • Journal of Medical Virology, July 2016, Wiley

    Jun Yong park

  16. Entecavir plus tenofovir combination therapy in patients with multidrug-resistant chronic hepatitis B: results of a multicentre, prospective study

    Article • Liver International, February 2016, Wiley

    Jun Yong park

  17. Early α-fetoprotein response predicts survival in patients with advanced hepatocellular carcinoma treated with sorafenib

    Article • Journal of Hepatocellular Carcinoma, April 2015, Dove Medical Press

    Jun Yong park

  18. Use of transient elastography to predict de novo recurrence after radiofrequency ablation for hepatocellular carcinoma

    Article • OncoTargets and Therapy, February 2015, Taylor & Francis

    Jun Yong park

  19. Transient elastography-based risk estimation of hepatitis B virus-related occurrence of hepatocellular carcinoma: development and validation of a predictive model

    Article • OncoTargets and Therapy, October 2013, Taylor & Francis

    Jun Yong park

  20. Orthotopic liver transplantation after the combined use of locoregional therapy and sorafenib for advanced hepatocellular carcinoma

    Article • OncoTargets and Therapy, June 2013, Taylor & Francis

    Jun Yong park

  21. Combined measurement of preoperative α‐fetoprotein and des‐γ‐carboxy prothrombin predicts recurrence after curative resection in patients with hepatitis‐B‐related hepatocellular carcinoma

    Article • International Journal of Cancer, March 2012, Wiley

    Jun Yong park